These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 28981954)

  • 1. Differential effect of the ultra-low dose and standard estrogen plus dydrogesterone therapy on thrombin generation and fibrinolysis in postmenopausal women.
    Piróg M; Jach R; Kacalska-Janssen O
    Acta Obstet Gynecol Scand; 2017 Dec; 96(12):1438-1445. PubMed ID: 28981954
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of ultra-low-dose versus standard hormone therapy on fibrinolysis and thrombin generation in postmenopausal women.
    Piróg M; Jach R; Undas A
    Eur J Obstet Gynecol Reprod Biol; 2017 Oct; 217():77-82. PubMed ID: 28865249
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibitors and activation markers of the haemostatic system during hormone therapy: a comparative study of oral estradiol (2 mg)/ dydrogesterone and estradiol (2 mg)/ trimegestone.
    Norris LA; Brosnan J; Bonnar J; Conard J; Kluft C; Hellgren M
    Thromb Haemost; 2008 Aug; 100(2):253-60. PubMed ID: 18690345
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Coagulation and fibrynolitic parameters in women and the effects of hormone therapy; comparison of transdermal and oral administration.
    Połać I; Borowiecka M; Wilamowska A; Nowak P
    Gynecol Endocrinol; 2013 Feb; 29(2):165-8. PubMed ID: 23116237
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of oral and transdermal estrogen/progesterone regimens on blood coagulation and fibrinolysis in postmenopausal women. A randomized controlled trial.
    Scarabin PY; Alhenc-Gelas M; Plu-Bureau G; Taisne P; Agher R; Aiach M
    Arterioscler Thromb Vasc Biol; 1997 Nov; 17(11):3071-8. PubMed ID: 9409295
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Changes in hemostatic parameters after oral hormone therapy in postmenopausal women.
    Borowiecka M; Polac I; Nowak P; Radwan P; Ponczek MB; Wachowicz B
    J Womens Health (Larchmt); 2010 Dec; 19(12):2267-70. PubMed ID: 21054215
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effects of hormone replacement therapy on thrombin generation, fibrinolysis inhibition, and resistance to activated protein C: prospective cohort study and review of literature.
    Douketis JD; Gordon M; Johnston M; Julian JA; Adachi JR; Ginsberg JS
    Thromb Res; 2000 Jul; 99(1):25-34. PubMed ID: 11012376
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oral ultra-low dose continuous combined hormone replacement therapy with 0.5 mg 17β-oestradiol and 2.5 mg dydrogesterone for the treatment of vasomotor symptoms: results from a double-blind, controlled study.
    Stevenson JC; Durand G; Kahler E; Pertyński T
    Maturitas; 2010 Nov; 67(3):227-32. PubMed ID: 20688442
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of hormone replacement therapy on coagulation and fibrinolysis in postmenopausal women.
    Koh KK
    Int J Hematol; 2002 Aug; 76 Suppl 2():44-6. PubMed ID: 12430899
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of low-dose oral and transdermal estrogen replacement therapy on hemostatic factors in healthy postmenopausal women: a randomized placebo-controlled study.
    Post MS; van der Mooren MJ; van Baal WM; Blankenstein MA; Merkus HM; Kroeks MV; Franke HR; Kenemans P; Stehouwer CD
    Am J Obstet Gynecol; 2003 Nov; 189(5):1221-7. PubMed ID: 14634544
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of oral and transdermal estrogen replacement therapy on markers of coagulation, fibrinolysis, inflammation and serum lipids and lipoproteins in postmenopausal women.
    Vehkavaara S; Silveira A; Hakala-Ala-Pietilä T; Virkamäki A; Hovatta O; Hamsten A; Taskinen MR; Yki-Järvinen H
    Thromb Haemost; 2001 Apr; 85(4):619-25. PubMed ID: 11341495
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Short-term effects of estrogen, tamoxifen and raloxifene on hemostasis: a randomized-controlled study and review of the literature.
    Cosman F; Baz-Hecht M; Cushman M; Vardy MD; Cruz JD; Nieves JW; Zion M; Lindsay R
    Thromb Res; 2005; 116(1):1-13. PubMed ID: 15850603
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of hormone-replacement therapy on fibrinolysis in postmenopausal women.
    Koh KK; Mincemoyer R; Bui MN; Csako G; Pucino F; Guetta V; Waclawiw M; Cannon RO
    N Engl J Med; 1997 Mar; 336(10):683-90. PubMed ID: 9041098
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hormone therapy and hemostasis among postmenopausal women: a review.
    Canonico M
    Menopause; 2014 Jul; 21(7):753-62. PubMed ID: 24937030
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of pulsed estrogen therapy on hemostatic markers in comparison with oral estrogen regimen in postmenopausal women.
    Basurto L; Saucedo R; Zárate A; Martínez C; Gaminio E; Reyes E; Hernandez M
    Gynecol Obstet Invest; 2006; 61(2):61-4. PubMed ID: 16192735
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Changes in hemostatic parameters after oral and transdermal hormone therapy in postmenopausal women.
    Polac I; Borowiecka M; Wilamowska A; Bijak M; Ponczek MB; Nowak P
    Gynecol Endocrinol; 2011 Sep; 27(9):692-5. PubMed ID: 20979540
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Age dependence of blood fibrinolytic components and the effects of low-dose oral contraceptives on coagulation and fibrinolysis in teenagers.
    Siegbahn A; Ruusuvaara L
    Thromb Haemost; 1988 Dec; 60(3):361-4. PubMed ID: 3149043
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of two oral doses of 17beta-estradiol associated with dydrogesterone on thrombin generation in healthy menopausal women: a randomized double-blind placebo-controlled study.
    Rousseau A; Robert A; Gerotziafas G; Torchin D; Zannad F; Lacut K; Libersa C; Dasque E; Démolis JL; Elalamy I; Simon T
    Fundam Clin Pharmacol; 2010 Apr; 24(2):239-45. PubMed ID: 19719551
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of hormone therapy on the enteroinsular axis.
    Sztefko K; Rogatko I; Milewicz T; Józef K; Tomasik PJ; Szafran Z
    Menopause; 2005; 12(5):630-638. PubMed ID: 16145319
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of ultra-low-dose estradiol and dydrogesterone on arterial stiffness in postmenopausal women.
    Matsui S; Yasui T; Tani A; Kato T; Uemura H; Kuwahara A; Matsuzaki T; Arisawa K; Irahara M
    Climacteric; 2014 Apr; 17(2):191-6. PubMed ID: 24164272
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.